&nbsp;

DerekMcNally.jpg

Aug 2023

Données sur l’utilisation des médicaments biosimilaires en oncologie

Regimen

DOST(MNT); CRBPPACL+DOST

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Dostarlimab - Primary Advanced or Recurrent MSI-H or dMMR Endometrial Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2025

Regimen

GLOF; GLOF(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

High Cost Therapy Funding Program

Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

Drugs Used:

oBINutuzumab,

glofitamab

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Document

dapColorectal15Feb2024.xml

Feb 2024

Document

dapColorectal15Feb2024.html

Feb 2024

Document

dapProstate15Feb2024.xml

Feb 2024

Document

dapProstate15Feb2024.html

Feb 2024

Regimen

GEMC+PEMB(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer

Drugs Used:

pembrolizumab,

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2024

Document

DrMonikaKrzyzanowska.png

Aug 2024

Regimen

GEMC+RAMU

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Drugs Used:

ramucirumab (Unfunded),

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Oct 2024

Document